Refractory Epilepsy
Refractory epilepsy is a form of epilepsy that does not respond to typical anti-seizure medications, leading to frequent seizures that can significantly impact daily life.
Focal Onset Seizures: Extended-Release Levetiracetam Study
We are testing a new once-daily version of levetiracetam for people with drug-resistant focal onset seizures. The study aims to see if it reduces seizure frequency better than current treatments and a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 12 and 80 years old?
- Do you have a diagnosis of epilepsy with focal-onset seizures (FOS)?
- Are you currently taking any medications for seizures, such as Levetiracetam, Lamotrigine, or Carbamazepine?
- Are you currently pregnant, breastfeeding, or planning to become pregnant during the study?
- Do you have any major health issues like heart, liver, or kidney disease?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Levetiracetam
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Cezarius
Cinaz
Desitrend
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Mnogoprofilna Bolnitsa Za Aktivno Lechenie Puls AD
Department of Nervous Diseases
Blagoevgrad, Bulgaria
Medical Center Vita 1 Ltd.
Neurology
Pleven, Bulgaria
Alexandrovska University Hospital
Clinic Of Nervous Diseases
Sofia, Bulgaria
Sponsor: Neuraxpharm Pharmaceuticals S.L.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.